普洛藥業(000739.SZ)與Bracco就兩個CDMO項目的生產和供應等條款達成約定
格隆匯11月27日丨普洛藥業(000739.SZ)公佈,公司與Bracco公司合作多年,已經建立了良好的合作關係。雙方為進一步深化合作,本着“長期合作、共謀發展”的原則,在自願、平等和誠信的基礎上,於近日簽署了《戰略合作協議》,就兩個CDMO項目的生產和供應等條款達成約定。
Bracco Imaging S.p.A.屬於Bracco集團的子公司,是全球影像診斷試劑供應的龍頭企業。總部在意大利米蘭,主營醫用造影劑的開發,生產和銷售。
Bracco公司是一家全球領先的影像診斷試劑生產商,公司產品涵蓋所有主要的影像診斷相關的醫療產品:X-光成像(包括CT, 介入放射,心導管檢查)核磁共振(MRI)、超聲造影(CEUS)及核醫學,在未知的醫療領域,通過放射性示蹤劑和新穎的PET造影劑確定臨牀診斷,引導癌症患者的治療方案。其擁有強大的研發能力和全球客户資源。此次合作是公司根據發展戰略,為充分發揮雙方各自優勢,實現長期合作,進一步做優做強公司CDMO業務,提升公司的綜合競爭能力而開展的。該協議的簽署有助於雙方合作的進一步深化和發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.